Fast-growing point-of-care (POC) diagnostics market segments get a domestic boost

Domestic players have grown rapidly to compete with multinational companies (MNCs) in Asia-Pacific’s point-of-care (POC) diagnostics market. More domestic IVD firms are gaining ground in the region’s fastest-growing point-of-care (POC) diagnostics market segments such as cardiac and infectious diseases.

Domestic companies are making positive strategic manoeuvres, going beyond offering quality products, to bring their businesses forward. In China, local players maintain their market edge by broadening hospital coverage, particularly in lower-tier hospitals; and gaining footholds in hospital departments.

For more on the POC diagnostics market in Asia, download the report on “The future of POC testing in Asia-Pacific.”